SciELO - Scientific Electronic Library Online

 
vol.29 número4El apoyo nutricio intensivo mejora el estado nutricio y la composición corporal en niños gravemente desnutridos con parálisis cerebralLactancia materna y desarrollo cognitivo: valoración de la respuesta a la interferencia mediante el "test de los 5 dígitos" índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Resumen

GIRALDO VILLA, Adriana  y  HOSPITAL PABLO TOBON URIBE. Grupo de Soporte Nutricional Pediátrico et al. Use of fish oil lipid emulsions in hospitalized patients under 18 years old with abnormal results in liver tests associated with total parental nutrition. Nutr. Hosp. [online]. 2014, vol.29, n.4, pp.844-851. ISSN 1699-5198.  http://dx.doi.org/10.3305/nh.2014.29.4.7209.

Introduction: Prolonged Total Parental Nutrition (TPN) is associated with life-threatening complications in the pediatric population, being cholestasis one of the most important ones. The source of fatty acids, the amount of phytosterols and the dose of lipids in the nutritional support, have been linked to the development of this complication. Purpose: To describe the behavior of liver function tests in pediatric patients with TPN where lipid based omega 3 fatty acids (Omegaven®) were used. Methods: A retrospective research was made in a population of children under 18 years old where omega 3 fatty acids were used for a minimum of 8 days. Patients were initially classified into two groups: cholestasis and abnormal liver tests. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TB), direct bilirubin (DB) gamma glutamyl transferase (GGT) and alkaline phosphatase (AP) before and after treatment with Omegaven® was evaluated. Results: 33 patients met the inclusion criteria. At the end of treatment with Omegaven®, 82.4% of patients who initially presented cholestasis showed resolution or improvement. The group of patients with abnormal liver tests 18.8% progressed to cholestasis. Conclusions: Our study suggests that the use of Omegaven® in pediatric patients with TPN and DB > 2 mg/dL, seem to reverse or improve cholestasis while in patients with abnormal liver tests we still don't have clear effect.

Palabras clave : Cholestasis; Lipids; Omega 3 fatty acids; Parenteral nutrition; Fish oils; Liver disease.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons